Targeted Delivery of Biological PROTACs: A New Approach for Degrading Challenging Protein Targets
- Biological PROTACs act as novel intracellular mechanisms to degrade undruggable proteins
- Antibody-based nanoparticles effectively address challenges in intracellular protein delivery
- Achieving efficient, targeted degradation offers new treatments for various diseases, including autoimmune disorders